Consumer Staples / Packaged FoodsUpdated 2026-05-10 22:07 UTC

ASX/BIO stock hub

ASX/BIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/BIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

65M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/BIO

In the news

Latest news · ASX/BIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19

P25 11.6P50 14.4P75 23.4

Trailing P/E65.5

P25 10.9P50 15.5P75 33.6

ROE18.1

P25 -41.1P50 -0.7P75 10.5

ROIC4.8

P25 -17.1P50 1P75 7.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/BIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

AUD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	30
Employees Change	0%
Employees Change Percent	0
Enterprise value	AUD 64.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Packaged Foods
Isin	AU0000184137
Last refreshed	2026-05-10
Market cap	AUD 65M
Price	AUD 0.29
Price currency	AUD
Sector	Consumer Staples
Sic	2833
Symbol	asx/BIO
Website	https://www.biomeaustralia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.47%
EV Earnings	66.87x
EV/EBIT	116.57x
EV/EBITDA	78.28x
EV/FCF	180.06x
EV/Sales	2.92x
FCF yield	0.55%
Forward P/E	19x
P/B ratio	10.72x
P/E ratio	65.49x
P/S ratio	2.96x
PE Ratio3 Y	323.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.5%
EBITDA Margin	3.28%
FCF margin	1.62%
Gross margin	61.17%
Gross Profit	AUD 13.4M
Gross Profit Growth	19.29%
Gross Profit Growth Q	40.15%
Gross Profit Growth3 Y	19.29%
Gross Profit Growth5 Y	25.72%
Net Income	AUD 957,907
Net Income Growth	231.94%
Net Income Growth Q	171.5%
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Pretax Margin	4.36%
Profit Margin	4.36%
Profitable Years	1
ROA	3.02
Roa5y	-51.5
ROCE	8.06
ROE	18.09
Roe5y	-128.8
ROIC	4.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.06%
Cagr3y	50.85%
EPS Growth	228.2
EPS Growth Q	173.6
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth	38.44x
Revenue Growth Q	39.88x
Revenue Growth Quarters	13x
Revenue Growth Years	6x
Revenue Growth3 Y	19.06x
Revenue Growth5 Y	24.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.93
Assets	AUD 12.3M
Cash	AUD 3.4M
Current Assets	AUD 11M
Current Liabilities	AUD 5.5M
Debt	AUD 2.4M
Debt EBITDA	AUD 2.97
Debt Equity	AUD 0.4
Debt FCF	AUD 6.83
Equity	AUD 6.1M
Interest Coverage	3.31
Liabilities	AUD 6.2M
Long Term Assets	AUD 1.3M
Long Term Liabilities	AUD 756,461
Net Cash	AUD 924,822
Net Cash By Market Cap	AUD 1.42
Net Cash Growth	-32.19%
Net Debt EBITDA	AUD -1.28
Net Debt Equity	AUD -0.15
Net Debt FCF	AUD -2.6
Tangible Book Value	AUD 5.8M
Tangible Book Value Per Share	AUD 0.03
WACC	9.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2
Inventory Turnover	2.43
Net Working Capital	AUD 3.9M
Quick ratio	1.21
Working Capital	AUD 5.5M
Working Capital Turnover	AUD 4.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.04%
200-day SMA	0.43
3Y total return	243.37%
50-day SMA	0.35
50-day SMA vs 200-day SMA	50under200
All Time High	0.87
All Time High Change	-67.24%
All Time High Date	2024-09-20
All Time Low	0.06
All Time Low Change	375%
All Time Low Date	2023-06-08
ATR	0.01
Beta	1.02
Beta1y	1.31
Beta2y	0.89
Ch YTD	-32.14
High	0.29
High52	0.63
High52 Date	2025-07-15
High52ch	-54.76%
Low	0.28
Low52	0.27
Low52 Date	2026-05-05
Low52ch	5.56%
Ma50ch	-17.73%
Price vs 200-day SMA	-34.27%
RSI	33.67
RSI Monthly	39.68
RSI Weekly	30.33
Sharpe ratio	-0.69x
Sortino ratio	-0.91
Total Return	-0.7%
Tr YTD	-32.14
Tr1m	-14.93%
Tr1w	-1.72%
Tr3m	-36.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 549,489
Operating Income Growth Q	663.6
Operating margin	2.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,106,294%
Net Borrowing	357,640
Shares Insiders	29.2%
Shares Institutions	1.22%
Shares Out	227,998,033
Shares Qo Q	3.21%
Shares Yo Y	0.7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -50,785
Average Volume	227,294.45x
Bv Per Share	0.03
CAPEX	AUD -35,101
Ch1m	-14.93
Ch1w	-1.72
Ch1y	-38.04
Ch3m	-36.67
Ch3y	243.4
Ch6m	-35.23
Change	0%
Change From Open	0
Close	0.29
Days Gap	0
Depreciation Amortization	170,742
Dollar Volume	24,940.1
Earnings Date	2026-05-22
EBIT	AUD 549,489
EBITDA	AUD 720,231
EPS	AUD 0
F Score	6
FCF	AUD 355,741
FCF EV Yield	0.56x
FCF Per Share	AUD 0
Financing CF	518,568
Fiscal Year End	June
Founded	2,018
Graham Number	0.05163
Graham Upside	-81.88
Investing CF	-140,476
Is Primary Listing	1
Last Earnings Date	2026-01-28
Last Report Date	2025-12-31
Ma150	0.41
Ma150ch	-30.06%
Ma20	0.32
Ma20ch	-10.26%
Net CF	768,934
Next Earnings Date	2026-05-22
Open	0.29
P FCF Ratio	182.7
P OCF Ratio	166.3
Position In Range	71.43
Ppne	1,078,517
Price Date	2026-05-08
Price EBITDA	AUD 90.22
Ptbv Ratio	11.17
Relative Volume	0.37x
Revenue	21,952,577x
SBC By Revenue	1.85x
Share Based Comp	406,526
Tr6m	-35.23%
Volume	87,509
Z Score	10.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/BIO pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/BIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/BIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+29.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

ASX/BIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.7

Neutral momentum band

Price vs 200-day MA

-34.3%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

-0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/BIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/BIO stock rating?

asx/BIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/BIO analysis?

The full report lives at /stocks/asx/BIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/BIO?

The latest report frames asx/BIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/BIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.